Discovery of bioactive peptides as therapeutic agents for skin wound repair
Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs

Foods containing potassium (such as bananas, oranges, potatoes, and leafy greens) are part of a balanced diet, but avoid making significant dietary changes or taking supplements that increase potassium intake without medical advice, particularly if you have kidney disease or take medications such as ACE inhibitors, ARBs, or potassium-sparing diuretics
Biomaterials, 32(3), 785-795